B-Raf inhibitor 1 is a potent Raf kinase inhibitor used to inhibit the proliferation of cancer cell lines such as A375 and HCT-116 (with IC50 values of 0.31 μM and 0.72 μM, respectively); it binds to and stabilizes B-Raf in a DFG-out, inactive conformation, and exhibits activity against wild-type B-Raf, B-Raf V600E, and C-Raf (with Ki values of 1 nM, 1 nM, and 0.3 nM, respectively), suggesting potential applications in targeting Raf-dependent cancers and Raf dimer-driven signaling pathways.